Yazar "Mergen, Sena" seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Intravascular B-cell lymphoma with generalized telangiectasias(Wiley, 2023) Erol, Vedat Buğra; Mutlu, Yaşa Gül; Balık, Berrin; Mert, Ali; Mergen, Sena; Mergen, Mahmut; Serin, İstemi; Çakır, Aslı; Özden, Ferhat; Sevindik, Ömür Gökmen[Abstract Not Available]Öğe To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission(Springer Science and Business Media Deutschland GmbH, 2022) Sevindik, Ömür Gökmen; Mergen, Mahmut; Mergen, Sena; Mutlu, Yaşa Gül; Balık Aydın, Berrin; Serin, İstemiDear Editor, Acute myeloid leukemia is the most common sub-type of acute leukemia in adulthood [1]. It has a detrimental prognosis with conventional combination chemotherapy, mainly with anthracyclines and cytarabine. Allogeneic stem cell transplantation has signifcantly prolonged the overall survival in a particular “eligible” patient population, but as AML is a disorder of the elderly, not all patients are able to proceed with allogeneic stem cell transplantation.
